A series of 5-arylidene-4-thiazolidinone derivatives were designed and synthesized.
All the synthesized compounds displayed potent to moderate AR inhibitory activity.
Selected ARI showed to reduce NF-kB and iNOS levels in human keratinocytes.
Molecular docking of some compounds supported the rationalization of binding mode.